切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2021, Vol. 15 ›› Issue (02) : 150 -153. doi: 10.3877/cma.j.issn.1674-3946.2021.02.010

所属专题: 文献

论著

改良Devine术在晚期不可切除远端胃癌中应用效果评价
王伟1, 马成民2, 汤东1, 汪刘华1, 孟庆洋1, 王道荣1,()   
  1. 1. 225001 江苏省苏北人民医院,扬州大学临床医学院,扬州大学-扬州市普通外科研究所
    2. 116044 大连医科大学扬州临床医学院
  • 收稿日期:2020-06-19 出版日期:2021-04-26
  • 通信作者: 王道荣

Clinical evaluation of Modified Devine exclusion for patients with unresectable distal gastric cancer

Wei Wang1, Chengmin Ma2, Dong Tang1, Liuhua Wang1, Qingyang Meng1, Daorong Wang1,()   

  1. 1. YangZhou University-Yangzhou Institute of General Surgery, Subei People's Hospital of Jiangsu province, Yangzhou University Clinical Medical College, Jiangsu 225001, China
    2. Yangzhou Clinical Medical College of Dalian Medical University, Liaoning 116044 , China
  • Received:2020-06-19 Published:2021-04-26
  • Corresponding author: Daorong Wang
  • Supported by:
    National Natural Science Foundation of China(81871317)
引用本文:

王伟, 马成民, 汤东, 汪刘华, 孟庆洋, 王道荣. 改良Devine术在晚期不可切除远端胃癌中应用效果评价[J]. 中华普外科手术学杂志(电子版), 2021, 15(02): 150-153.

Wei Wang, Chengmin Ma, Dong Tang, Liuhua Wang, Qingyang Meng, Daorong Wang. Clinical evaluation of Modified Devine exclusion for patients with unresectable distal gastric cancer[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(02): 150-153.

目的

探讨不同两种术式应用晚期不可切除远端胃癌患者的安全性及可行性。

方法

回顾性分析2012年9月至2019年9月期间行手术治疗的61例晚期远端不可切除胃癌患者的临床资料。其中25例行改良Devine术(改良组),36例行传统胃空肠吻合术(传统组)。采用SPSS 21.0统计软件包进行分析,围术期各项指标以(±s)表示,采用独立样本t检验;术后并发症比较采用χ2检验;患者术后满意度比较采用U检验。P<0.05为差异有统计学意义。

结果

两组患者手术平均时间、失血量、术后通气时间,进食时间、住院时间及患者术后1个月白蛋白增加等指标,差异无统计学意义(P均>0.05)。传统组有6例(16.7%)发生了胃排空障碍,而改良组未发生胃排空障碍,差异有统计学意义(P=0.032);改良组术后总并发症发生率4.0%明显低于传统组22.2%,差异有统计学意义(P=0.048);改良组患者术后满意度明显高于传统组,差异有统计学意义(P=0.016)。

结论

改良Devine术可明显缓解症状,术后并发症低,患者满意度高是一种安全有效的手术方式,值得推广应用。

Objective

To investigate the safety and feasibility of two different surgical methods for patients with unresectable distal gastric cancer.

Methods

Clinical data of 61 patients with unresectable distal gastric cancer who underwent surgical treatment from September 2012 to September 2019 were analyzed retrospectively. Among them, 25 cases underwent modified Devine operation (modified group), and 36 cases underwent traditional gastrojejunostomy (traditional group). Statistical analysis were performed by using SPSS21.0 software package. The perioperative indicators were expressed as (±s) and were analyzed by using independent sample t-test. The postoperative complications were compared by using χ2 test. The postoperative satisfaction of patients were compared by using Mann-Whitney U test. A P value of <0.05 was considered as statistically significant difference.

Results

There were no significant difference between two groups, in terms of the average operation time, blood loss, postoperative ventilation time, eating time, hospitalization time and ALB increase at 1 month after operation (P>0.05). There were 6 cases (16.7%) of gastric emptying disorder in the traditional group, while no gastric emptying disorder occurred in the modified group, with statistically significant difference (P=0.032). The total postoperative complication rate of 4.0% in the improved group was significantly lower than 22.2% in the traditional group, with statistically significant difference (P=0.048). The postoperative satisfaction of patients in improved group was signifcantly high than that in traditional group, with statistically significant difference (P=0.016).

Conclusion

Modified Devine operation could significantly relieve the symptoms and reduce the postoperative complications and improve satisfaction. It is a safe and effective surgical method, which is worthy of promotion and application.

表1 61例晚期不可切除远端胃癌不同术式两组患者的基线资料对比[(±s),例]
图1 改良Devine术示意图
图2 胃空肠吻合术示意图
表2 61例晚期不可切除远端胃癌不同术式两组患者围术期指标对比[(±s),例]
表3 61例晚期不可切除远端胃癌不同术式两组患者的并发症资料对比[例(%)]
表4 61例晚期不可切除远端胃癌患者不同术式患者及家属满意度调查[例(%)]
[1]
Tan ZY. Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review[J]. Med Sci Monit, 2019, 25, 3537-3541.
[2]
Kwon SJ. Bypass Surgery in Unresectable Distal Gastric Cancer[J]. J Korean Surg Soc, 1999, 57(Suppl): 984-989.
[3]
日本胃癌學會. 胃癌治療ガイドライン[M]. 5版. 東京:金原出版株式会社,2018.
[4]
Kaminishi M, Yamaguchi H, Shimizu N, et al.Stomach-partitioning gastrojejunostomy for unresectable gastriccarcinoma[J]. Arch Surg, 1997, 132(2): 184-187.
[5]
Ojima T, Nakamori M, Nakamura M, et al. Laparoscopic Gastrojejunostomy for Patients with Unresectable Gastric Cancer with Gastric Outlet Obstruction[J]. J Gastrointest Surg, 2017, 21(8): 1220-1225.
[6]
Shinde A, Novak J, Amini A, et al. The evolving role of Laparoscopic therapy for resectable and unresectable gastric cancer[J]. Transl Gastroenterol Hepatol, 2019, 4: 64.
[7]
刘昊,徐泉,马福海,等. 全腹腔镜胃部分离断后胃肠吻合术治疗胃癌合并幽门梗阻的临床效果[J].中华肿瘤杂志,2020,42(6):445-448.
[8]
魏波,卫洪波.进展期胃癌的外科治疗策略[J]. 中华胃肠外科杂志,2018,21(10):1099-1102.
[9]
Wang TB, Wang NC, Ren H, et al. Long-term Results of Conversion Therapy for Initially Unresectable Gastric Cancer: Analysis of 122 Patients at the National Cancer Center in China[J]. J Cancer, 2019, 10(24): 5975-5985.
[10]
崔航天,罗天航.不可切除胃癌转化治疗的研究进展[J]. 上海医学,2017.40(12):771-774.
[11]
Lopez-Sanchez J, Martin AF, Fernandez O A-L, et al. Stomach-partitioning Gastrojejunostomy Versus Stent Placement for the Treatment of Malignant Gastric Outlet Obstruction[J]. Cir Esp, 2019, 97(7): 385-390.
[12]
Kwok SP, Chung SC, Griffin SM, et al. Devine exclusion for unresectable carcinoma of the stomach[J]. Br J Surg, 1991, 78(6): 684-685.
[13]
Mamos MFKP, Barchi LC, de Oliveira RJ, et al. Gastric partitioning for the treatment of malignant gastric outlet obstruction[J]. World J Gastrointest Oncol, 2019, 11(12): 1161-1171.
[14]
Fernandez-Moreno MC, Marti-Obiol R, Lopez F, et al. Modified Devine Exclusion for Unresectable Distal Gastric Cancer in Symptomatic Patients[J]. Case Rep Gastroenterol, 2017, 11(1): 9-16.
[15]
Ojima T, Nakamori M, Nakamura M, et al. Laparoscopic Gastrojejunostomy for Patients with Unresectable Gastric Cancer with Gastric Outlet Obstruction[J]. J Gastrointest Surg, 2017, 21(8): 1220-1225.
[16]
Min S-H, Son S-Y, Jung D-H, et al. Laparoscopic stomach partitioning-gastrojejunostomy versus duodenal stenting in unreseetable gastric cancer with gastric outlet obstruction[J]. Ann Surg Treat Res, 2017, 93(3): 130-136.
[17]
王静铭,邢俊杰,刘宏,等. 3D腹腔镜与2D腹腔镜辅助远端胃癌D2根治术的应用对比[J/CD]. 中华普外科手术学杂志(电子版),2018,12(2):115-118.
[1] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[2] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[3] 闫笑生, 郑智, 翟育豪, 张海翘, 王鈢, 刘小野, 尹杰, 张军. Borrmann Ⅳ型胃癌临床诊断、病理特征及预后分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 346-351.
[4] 王龙彪, 刘洪, 董天雄. 中心体扩增细胞占比和C反应蛋白-白蛋白比值对胃癌根治术治疗预后的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 352-356.
[5] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[6] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[7] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[8] 唐浩, 梁平, 徐小江, 曾凯, 文拨辉. 三维重建指导下腹腔镜右半肝加尾状叶切除治疗Bismuth Ⅲa型肝门部胆管癌的临床研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 688-692.
[9] 张彬, 贾贵清, 吴东松, 曹绿洲, 张焰凌, 黄灏, 赵高平. 早期胃癌保功能手术治疗13例病例分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 575-579.
[10] 王鸿彬, 何晓, 吴菁宙. 腹腔镜近端胃切除术中背驮式间置空肠单通道重建术在AEG手术的安全性及抗反流效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 526-529.
[11] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[12] 高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[13] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[14] 范伟强, 林师佈, 孙传伟, 宋奇锋, 李望, 符誉, 陈艾. 不同切除范围的Bismuth-Corlette Ⅲ、Ⅳ型腹腔镜肝门部胆管癌手术临床对比分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 423-426.
[15] 徐瑜杰, 赵国栋. 晚期胃癌治疗方法的研究进展和挑战[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 451-455.
阅读次数
全文


摘要